2009
DOI: 10.1002/pbc.22048
|View full text |Cite
|
Sign up to set email alerts
|

Multi‐modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30‐day readmission rate

Abstract: Introduction-The National Association of Children's Hospitals (NACHRI) and the Centers for Medicare and Medicaid Services (CMS) recently introduced 30-day hospital readmission rate as a quality care indicator in children with Sickle Cell Disease (SCD). Based on previous research identifying risk factors for 30-day readmission in our patient population, we designed and implemented a multi-modal intervention to reduce 30-day readmission rate in children with SCD and pain.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2010
2010
2013
2013

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 9 publications
0
19
0
Order By: Relevance
“…However, to date there have been few studies to validate this marker and debate remains as to its value. One single-institution study identified co-morbid asthma, oxygen within 24 hr of discharge, disease severity and lack of clinic follow-up within 30 days as factors associated with higher risk of readmission, however, their study design did not allow for an actual estimate of readmission rates [6,8]. A NACHRI, multi-state study of sickle cell disease care utilization found an overall readmission rate of 33.4%, with lower rates in children (12.8% in children age 1–9 and 23.4% for patients ages 10–17); however, it did not examine factors other than age associated with readmission [9].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, to date there have been few studies to validate this marker and debate remains as to its value. One single-institution study identified co-morbid asthma, oxygen within 24 hr of discharge, disease severity and lack of clinic follow-up within 30 days as factors associated with higher risk of readmission, however, their study design did not allow for an actual estimate of readmission rates [6,8]. A NACHRI, multi-state study of sickle cell disease care utilization found an overall readmission rate of 33.4%, with lower rates in children (12.8% in children age 1–9 and 23.4% for patients ages 10–17); however, it did not examine factors other than age associated with readmission [9].…”
Section: Introductionmentioning
confidence: 99%
“…Corticosteroids have also been implicated in higher sickle cell readmission rates, specifically after a diagnosis of acute chest syndrome [10,11], although this has not been shown in all studies [12]. Use of a standardized sickle cell pain plan has been show to reduce readmission rates [8,13]. Finally, work in other diseases has identified African-American race, public insurance, neighborhood conditions, including high measures of poverty, patient complexity, disease severity, and weekend discharge as factors leading to greater risk of readmission with comprehensive discharge planning being shown to reduce readmissions rates [1316].…”
Section: Introductionmentioning
confidence: 99%
“…15 Despite the development of national guidelines for the management of SCD pain and other complications, 1,16 clinical practice and rates of acceptable care remain variable, 17,18 with patients with SCD experiencing high inpatient and emergency department readmission rates. 19-21 …”
Section: Introductionmentioning
confidence: 99%
“…Several factors associated with inadequate analgesia have been described: assumptions of health care practitioners about possible drug-seeking behaviors; frequent ED visits by some patients; and predominance of African-American race. In fact, aggressive pain treatment administered according to specific clinical practice guidelines [24][25][26][27] resulted in significant decrease in waiting time for analgesia, analgesic dosing, increase use of validated pain scale, 28 and reduction of 30-day readmission rate 29 in the United States. Inadequate analgesia for SCD patients and long time to analgesics provision for pain in the ED 20 have been recently demonstrated even in countries with long-established experience in the management of SCD patients, suggesting that addressing these topics requires long-term interventions.…”
Section: Discussionmentioning
confidence: 99%